In COVID‐19 patients both CD3+CD4+ and CD3+CD8+ effector memory cells, transitional B cells and plasmablast levels were higher, while CD25+Foxp3+ T regulatory cells were lower than in subjects without COVID‐19. This evidence concerns the gene CD4 and COVID-19.